Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon

Table 3 Logistic regression of patient characteristics associated with treatment outcomes in the first 6 months after initiating ART

Characteristics	Disappeared (n = 51)		Died (n = 28)
	Odds ratio (95%CI)	P-value	Odds ratio (95%CI)	P-value
Age (years)		0.65		0.23
<30	0.98 (0.45-2.15)		0.39 (0.11-1.35)
30-49	1		1
≥ 50	1.55 (0.61-3.96)		0.58 (0.13-2.65)
Sex		0.09		0.37
Male	1		1
Female	0.58 (0.31-1.08)		0.68 (0.30-1.55)
Monthly income (USD)		0.9		0.43
<USD50	1.19 (0.55-2.59)		0.92 (0.32-2.63)
USD50 - USD125	1		1
>USD125	1.09 (0.44-2.68)		1.67 (0.57-4.90)
Education		0.44		0.51
Primary	1		1
Secondary without bachelor	1.38 (0.67-2.84)		1.71 (0.64-4.58)
Secondary with bachelor or university	0.79 (0.26-2.39)		1.77 (0.49-6.01)
Travel time to clinic (hour)		0.47		0.97
<1	1		1
1-4	1.30 (0.62-2.72)		1.02 (0.39-2.71)
>4	1.93 (0.65-5.75)		1.22 (0.26-5.77)
Baseline CD4-cell count (cells/μl)		0.86		0.02
<100	1.06 (0.57-1.97)		2.69 (1.12-6.44)
≥ 100	1		1
Clinical stage		<0.001		0.11
CDC stage A	1		1
CDC stage B	5.72 (1.33-24.70)		2.08 (0.59-7.35)
CDC stage C	16.9 (3.58-80.30)		4.52 (1.04-19.70)
ART side-effects at 1 month		0.71		0.638
No side-effects	1		1
One or more side-effects	1.24 (0.40-3.85)		1.43 (0.30-6.73)
ART side-effects at 1 month		0.14		0.001
Improving	0.49 (0.19-1.26)		0.11 (0.02-0.52)
Not improving	1		1
Disclosure of HIV status		0.22		0.93
Yes	1		1
No	1.10 (0.95-1.27)		1.01 (0.79-1.29)

Patients who disappeared (n = 51) or died (n = 28) are compared with patients with complete follow-up or transferred (n = 233). OR were calculated using logistic regression, p-values from the likelihood ratio test.

ISSN: 1742-6405